TY - JOUR
T1 - Endovascular Therapy for Acute Ischemic Stroke
T2 - A Comprehensive Review of Current Status
AU - Kilic, İsmail D
AU - Hakeem, Abdul
AU - Marmagkiolis, Konstantinos
AU - Paixao, Andre
AU - Grunwald, Iris
AU - Mutlu, Deniz
AU - AbouSherif, Sara
AU - Gundogdu, Betul
AU - Kulaksizoglu, Sibel
AU - Ates, Ismail
AU - Wholey, Mark
AU - Goktekin, Omer
AU - Cilingiroglu, Mehmet
N1 - Copyright © 2018. Published by Elsevier Inc.
PY - 2019/5/9
Y1 - 2019/5/9
N2 - Stroke remains among the leading causes of disability and death worldwide. Fibrinolytic therapy is associated with poor patency and functional outcomes. Recently, multiple randomized trials have been published that have consolidated the role of endovascular therapy for ischemic stroke due to large vessel occlusion in the anterior cerebral circulation. This manuscript reviews the current understanding of the endovascular management of acute stroke including technical aspects and current evidence base.
AB - Stroke remains among the leading causes of disability and death worldwide. Fibrinolytic therapy is associated with poor patency and functional outcomes. Recently, multiple randomized trials have been published that have consolidated the role of endovascular therapy for ischemic stroke due to large vessel occlusion in the anterior cerebral circulation. This manuscript reviews the current understanding of the endovascular management of acute stroke including technical aspects and current evidence base.
KW - Brain Ischemia/diagnostic imaging
KW - Cerebral Angiography
KW - Disability Evaluation
KW - Endovascular Procedures/adverse effects
KW - Humans
KW - Recovery of Function
KW - Risk Factors
KW - Stroke/diagnostic imaging
KW - Time Factors
KW - Time-to-Treatment
KW - Treatment Outcome
U2 - 10.1016/j.carrev.2018.07.010
DO - 10.1016/j.carrev.2018.07.010
M3 - Review article
C2 - 30025660
SN - 1878-0938
VL - 20
SP - 424
EP - 431
JO - Cardiovascular revascularization medicine : including molecular interventions
JF - Cardiovascular revascularization medicine : including molecular interventions
IS - 5
ER -